Sponsor or institution
Clinical trials and research at Serodopa Therapeutics INC
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
NX90: a faster overdose treatment for fentanyl and other powerful opioids
NX90 is a new naloxone-derived antidote designed to quickly restore breathing for people who overdose on fentanyl and other high-potency opioids.
-
A new treatment for overdose caused by powerful opioids
This study is testing a new treatment that could help people who have overdosed on strong opioids like fentanyl, aiming to work faster and with fewer side effects than current options, so that those in crisis can get better help more quickly.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.